sec whistleblower attorneys
July 02, 2020
Alexion Pharmaceuticals Inc.
FCPA
SANCTION AMOUNT: $21476531
Defendants: Alexion Pharmaceuticals Inc.
Respondent agreed to settle charges that it violated the books and records and internal controls provisions of the Foreign Corrupt Practices Act, based on payments to government officials over roughly a 5-year span by Turkish and Russian subsidiaries to secure favorable treatment for Respondent’s primary drug, Soliris.
- Key Docs
- Official SEC press release
